The treatment of head and neck cancer by radiotherapy has undergone significant evolution over recent years. Modern protocols combine highly conformal intensity‐modulated radiotherapy (IMRT) with ...
Two new exploratory studies of radioenhancers used in combination with radiation therapy in the treatment of head and neck cancers showed that these agents can boost the effectiveness of radiotherapy ...
In definitive radiotherapy, reducing the elective dose from 50 Gy to 43 Gy was safe and did not significantly increase the risk for recurrence in electively irradiated lymph nodes among patients with ...
Oral stents have emerged as a valuable adjunct in the radiotherapy of head and neck cancer, allowing clinicians to displace and immobilise non-target tissues, thereby reducing radiation exposure to ...
Head and neck cancer is a broad term for several types of cancers that include the mouth (oral cavity), throat (pharynx), voice box (larynx), sinuses and nose cavity, and salivary glands. Head and ...
Recent results from the phase III NRG Oncology RTOG 0920 (NRG-RTOG 0920) trial assessing postoperative radiotherapy with or without concurrent cetuximab for selected patients with squamous cell cancer ...
Please provide your email address to receive an email when new articles are posted on . Hypofractionated radiotherapy proved noninferior to conventional radiotherapy in head and neck cancer subtype.
A new study evaluates an artificial intelligence (AI)-based algorithm for autocontouring prior to radiotherapy in head and neck cancer. Manual contouring to pinpoint ...
Please provide your email address to receive an email when new articles are posted on . Patients who received nivolumab had longer DFS than those who received standard care. OS will be evaluated after ...
SHREVEPORT, La. - A new landmark study published in The Lancet is changing how doctors treat certain head and neck cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback